As one of the effective means of precision medicine, Nucleic Acid-based Medicines can directly act on the target genes or target mRNA and regulate the expression of the therapeutic genes from the root. The RNA-based medicines have greatly expanded the range of selectable targets of innovative drugs, making the previously undruggable targets possible. In recent years, with the maturation of technologies for chemical modification, nucleic acids delivery and manufacturing, RNA-based Therapeutics is expanding rapidly with multiple products launch onto the market, showing increasingly prominent clinical advantage and market value. At the same time, mRNA vaccines have entered a rapid development phase in the context of the COVID-19 pandemic. According to Sullivan's analysis, a total of 132 mRNA drugs have entered the clinical pipeline worldwide, and the research and development is mainly focused on the field of vaccines. In addition, mRNA has great potential in immunotherapy, protein replacement therapy, cell therapy, regenerative medicine and other fields. In Return, the xRNA Therapeutics Development and Innovation Forum 2024 will gather leaders and scientists across RNA-based medicines Innovators, leading academic centers and institutes for the discussion and case studies with the aim to facilitate the communication and partnership for the development, delivery and manufacturing of the next generation mRNA/circRNA-based Vaccines/Therapeutics and Oligonucleotide Drugs.

Session 1: mRNA and circRNA Vaccines and Therapeutics 
Session 2: mRNA Cancer Vaccine Development
Session 3: mRNA Novel Applications (Cell Therapy, Gene Editing and Regenerative Medicines etc.)
Session 4: mRNA Vaccine Process Development, Analytical Development and Quality Control
Session 5: Oligonucleotide Therapeutics Research and Development (ASO, siRNA, saRNA etc.)
Session 6: Oligonucleotide Therapeutics Process Development, Analytical Development and Quality Control
Session 7: Delivery Strategies and Technology for RNA-based Therapeutics

For the up-to-date Session Speakers and Confirmed Topics, please visit here